DNA icon

Thanatophoric Dysplasia (TD) via the FGFR3 Gene

Summary and Pricing

Test Method

Bi-Directional Sanger Sequencing
Test Code Test Copy GenesTest CPT Code Gene CPT Codes Copy CPT Codes Base Price
426 FGFR3 81479 81479 $520 Order Options and Pricing
Test Code Test Copy Genes Test CPT Code Gene CPT Codes Copy CPT Code Base Price
426FGFR381479 81479 $520 Order Options and Pricing

Pricing Comments

CNV detection may be ordered through Test #600.

An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.

Turnaround Time

12 days on average for standard orders or 8 days on average for STAT orders.

Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.

Targeted Testing

For ordering sequencing of targeted known variants, go to our Targeted Variants page.

EMAIL CONTACTS

Genetic Counselors

Geneticist

  • Juan Dong, PhD, FACMG

Clinical Features and Genetics

Clinical Features

Thanatophoric dysplasia (TD) is a short-limb dwarfism syndrome that is usually lethal in the perinatal period. TD is divided into type I (OMIM #187600), characterized by micromelia with bowed femurs and, uncommonly, the presence of cloverleaf skull deformity of varying severity; and type II (OMIM #187601), characterized by micromelia with straight femurs and the uniform presence of moderate-to-severe cloverleaf skull deformity (Karczeski & Cutting. GeneReviews. 2008). Other features common to type I and type II include: short ribs, narrow thorax, macrocephaly, distinctive facial features, brachydactyly, hypotonia, and redundant skin folds along the limbs. Most affected infants die of respiratory insufficiency shortly after birth. Rare long-term survivors have been reported.

Genetics

Thanatophoric dysplasia (TD) is inherited in an autosomal dominant manner with complete penetrance. The majority of probands have a de novo gene variant. FGFR3 is the only gene known to be associated with TD type I and type II. A single FGFR3 variant (p.Lys650Glu) in exon 15 has been identified in all individuals with TD type II (Bellus et al. Am J Hum Genet 67:1411–1421, 2000). Sequence analysis of selected exons of FGFR3 (exons 7, 10, 15, and 19 for TD type I; and exon 15 for TD type II) detects up to 99% disease variants causing TD type I and >99% of variants causing TD type II (Wilcox et al. Am J Med Genet 78:274–281, 1998; Brodie et al. Am J Med Genet 84:476–480, 1999; Camera et al. Am J Med Genet 104:277–281, 2001). FGFR3 gene encodes fibroblast growth factor receptor-3, a member of the FGFR family. Like all of the FGFRs, FGFR3 is a membrane-spanning tyrosine kinase receptor with an extracellular ligand-binding domain consisting of three immunoglobulin subdomains, a transmembrane domain, and a split intracellular tyrosine kinase domain (Green et al. Bioessays 18:639–646. 1996).

Clinical Sensitivity - Sanger Sequencing

This test is predicted to detect up to 99% of disease variants causing TD type I and >99% of variants causing TD type II (Wilcox et al. 1998; Brodie et al. 1999; Camera et al. 2001).

Testing Strategy

This test involves bidirectional sequencing using genomic DNA of 4 selected coding exons (exon 7, 10, 15, 19) of the FGFR3 gene plus ~10 bp of flanking non-coding DNA on each side. We will also sequence any single exon (Test #100) in family members of patients with a known variant or to confirm research results.

Indications for Test

Candidates for this test are newborns with abnormal clinical and radiologic features consistent with TD, and patients with abnormal prenatal ultrasound results showing features suggestive of TD in the fetus.

Gene

Official Gene Symbol OMIM ID
FGFR3 134934
Inheritance Abbreviation
Autosomal Dominant AD
Autosomal Recessive AR
X-Linked XL
Mitochondrial MT

Related Tests

Name
FGFR3-Related Disorders via the FGFR3 Gene
Achondroplasia via the FGFR3 Gene, Exon 10
Craniofrontonasal Syndrome via the EFNB1 Gene
Craniosynostosis and Dental Anomalies, Autosomal Recessive Crouzon-like Craniosynostosis via the IL11RA Gene
Craniosynostosis via the MSX2 Gene
Frontonasal Dysplasia (Frontorhiny) via the ALX3 Gene
Hypochondroplasia via the FGFR3 Gene

Citations

  • Bellus, G. A., et.al. (2000). "Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype." Am J Hum Genet 67(6): 1411-21. PubMed ID: 11055896
  • Brodie, S. G., et.al. (1999). "Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations." Am J Med Genet 84(5): 476-80. PubMed ID: 10360402
  • Brodie, S. G., et.al. (1999). "Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations." Am J Med Genet 84(5): 476-80. PubMed ID: 10360402
  • Camera, G., et.al. (2001). "Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype." Am J Med Genet 104(4): 277-81. PubMed ID: 11754059
  • Camera, G., et.al. (2001). "Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype." Am J Med Genet 104(4): 277-81. PubMed ID: 11754059
  • Green, P. J., et.al. (1996). "Promiscuity of fibroblast growth factor receptors." Bioessays 18(8): 639-46. PubMed ID: 8760337
  • Karczeski, Barbara MS (2008). "Thanatophoric Dysplasia."
  • Wilcox, W. R., et.al. (1998). "Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia." Am J Med Genet 78(3): 274-81. PubMed ID: 9677066
  • Wilcox, W. R., et.al. (1998). "Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia." Am J Med Genet 78(3): 274-81. PubMed ID: 9677066

Ordering/Specimens

Ordering Options

We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.

myPrevent - Online Ordering

  • The test can be added to your online orders in the Summary and Pricing section.
  • Once the test has been added log in to myPrevent to fill out an online requisition form.
  • PGnome sequencing panels can be ordered via the myPrevent portal only at this time.

Requisition Form

  • A completed requisition form must accompany all specimens.
  • Billing information along with specimen and shipping instructions are within the requisition form.
  • All testing must be ordered by a qualified healthcare provider.

For Requisition Forms, visit our Forms page


Specimen Types

Specimen Requirements and Shipping Details

loading Loading... ×

ORDER OPTIONS

View Ordering Instructions

1) Select Test Method (Backbone)


1) Select Test Type


2) Select Additional Test Options

STAT and Prenatal Test Options are not available with Patient Plus.

No Additional Test Options are available for this test.

Note: acceptable specimen types are whole blood and DNA from whole blood only.
Total Price: $
×
Copy Text to Clipboard
×